The e antigen/antibody system was first described by Magnius and Espmark (1972) , who suggested that the presence of e antigen might indicate infectivity while the antibody occurred only in non-infectious HBsAg positive sera. The correlation of e antigen with large numbers of 'Dane' particles, and its absence in sera containing no 'Dane' particles (Nielsen et al., 1974; Neurath et al., 1976) , also seems to suggest a relationship to infectivity. Neurath et al. (1976) suggested that e antigen is present as an additional antigenic site on the surface of the 'Dane' particles and tubular forms of HBsAg as well as in the form of a soluble antigen. Nielsen et al. (1974) suggested that it might be a valuable prognostic marker because it was present in the sera of 58 % of cases of acute hepatitis B which progressed to chronic hepatitis or cirrhosis.
In the present study, the presence was determined of e antigen and antibody in sera from patients in two renal dialysis units in which the outbreaks of hepatitis B (during 1969-71) were quite different (Polakoff et al., 1972 Received for publication 31 January 1977 antigen and antibody. In unit A, consecutive serum samples were available from the patients for periods of five months to five years after the onset of antigenaemia. In unit B, serum samples were available from the patients from the onset of antigenaemia until they cleared HBsAg. Serum samples taken just before hepatitis B infection in the patients of both units were also examined for e and anti-e.
All the samples were first tested by immunoelectroosmophoresis (IEOP) for HBsAg activity.
The immunodiffusion test was used to detect e antigen and antibody. The gel consisted of 09% agarose (Indubiose, l'Industrie Biologique Francaise) in tris buffer. The test was performed in 5 cm Petri plates with the gel 3 mm thick. Six wells were cut surrounding a central well, each 6 mm in diameter with approximately 10 mm between the centres of the wells. Each well was twice filled with sera.
The anti-e serum was obtained from a blood donor who was a carrier of HBsAg. The standard e antigen was serum obtained from a carrier of HBsAg who had chronic liver disease. Reference e antigen and anti-e sera were kindly supplied by Dr J. 0. Nielsen (Copenhagen) and Dr L. 0. Magnius (Stockholm).
Results
The frequency of e antigen and antibody in the HBsAg carriers of two renal dialysis units is shown in Table 1 . In unit A, in which most of the individuals with HBs antigenaemia progressed to become carriers of HBsAg, all of those followed up except one was not related to the titre of HBsAg, as seen in Table  3 . (Eleftheriou et al., 1975; El Sheikh et al., 1975; Feinman et al., 1975; Nordenfelt and Kjellen, 1975; Vogten et al., 1976) . This report is concerned with the epidemiological significance of the e system. e Antigen and antibody in outbreaks of hepatitis B in two renal dialysis units
The two dialysis unit outbreaks have previously been compared (Polakoff et al., 1972) . In unit A, the classical pattern was observed, many of the patients experiencing very mild symptoms of hepatitis at the time HBsAg was first detected. Of the infected patients, 78% became established HBsAg carriers and all of these had e antigen detectable from the acute phase onwards. In only two cases (10%) did the e antigen disappear. Similar findings have been reported by . In their series, most of the patients showed histological evidence of chronic hepatitis. Of the six patients in unit A who cleared HBsAg five had e antigen at the onset of hepatitis. From this it appears that determinations of e have no prognostic value in prediciting the outcome of individual cases.
In unit B there were fewer patients and these experienced much more acute symptoms of hepatitis than is expected in dialysis unit outbreaks. Moreover, all cleared the antigen within four months of onset. Only 30% of the infected patients in the unit produced e antigen during their illness. Contrary to the results of Norkrans et al. (1976) in their study of acute hepatitis B, the presence of e antigen was not related to a longer duration of HBs antigenaemia.
There were marked differences in the detection of e antibody in these outbreaks. Only one patient in unit A produced anti-e shortly after the appearance of e antigen, and both were present transiently. In unit B, however, four of the 10 infected patients produced anti-e transiently just before they finally cleared HBsAg. It is unlikely that the difference in the courses of the hepatitis B outbreaks is due to different methods of selection or treatment of patients, nor can it be attributed to a difference in the subtype since ay was involved in both units. However, it does seem that e antigen and antibody determinations may be useful in predicting the course of dialysis outbreaks.
These results also suggest that the occurrence of e antigen or antibody could be related to the nature of the infecting strain rather than to the individual patient's response.
